Simms Michael J 4
4 · Alexza Pharmaceuticals Inc. · Filed Dec 30, 2009
Insider Transaction Report
Form 4
Simms Michael J
SVP, Operations & Manufact
Transactions
- Award
Stock Option (right to buy)
2009-12-28+49,626→ 49,626 totalExercise: $2.37Exp: 2019-12-27→ Common Stock (49,626 underlying)
Footnotes (1)
- [F1]Grant pursuant to the terms of the Issuer's 2009-2010 Performance Based Incentive Program (the "Performance Program") to Reporting Person of a stock option under the Issuer's 2005 Equity Incentive Plan (the "Plan"). 50% of such shares vest upon the Issuer's achievement of the approval of the New Drug Application (the "NDA") for the Issuer's AZ-004 (Staccato loxapine) product candidate (the "Second Milestone"), with the remaining 50% of such shares vesting upon the first anniversary of the achievement of the Second Milestone, provided that at the relevant vesting date the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan and the Reporting Person has at least a minimum personal performance rating of 70% under the Performance Program. The option expires ten years after the date of grant.